All Posts By

Smartkarma Daily Briefs

Daily Brief Singapore: Haw Par Corp and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Haw Par (HPAR SP) —2025 Update


Haw Par (HPAR SP) —2025 Update

By Michael Fritzell

  • Haw Par Corporation is a conglomerate owned by Singapore’s Wee family. It’s most famous for selling Tiger Balm — an ointment used for quick pain relief. But it also owns large stakes in commercial bank UOB and property developer UOL.

  • The business has continued to recover from COVID-19, when pharmacies had to close and tourism ground to a halt. Tiger Balm revenues are now back to their pre-COVID levels.

  • I get to an intrinsic value of SG$17.0 per share — well above the current share price of SG$11.8. And that’s assuming a 25% conglomerate discount.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: NIFTY Index, Aegis Vopak Terminals Ltd, Schloss Bangalore Ltd, Canara Bank and more

By | Daily Briefs, India

In today’s briefing:

  • Nifty 50 and the RBI Rate Decision: History Has a Pattern
  • Aegis Vopak IPO: Anemic Demand
  • Schloss Bangalore IPO Trading – Decent Anchor; Muted Overall Demand
  • Pair Trade Signal: LIC Housing Finance (LICHF IN) Long Vs. Canara Bank (CBK IN) Short


Nifty 50 and the RBI Rate Decision: History Has a Pattern

By Gaudenz Schneider

  • The Reserve Bank of India (RBI) is set to announce a monetary policy decision on Friday, 6 June 2025.
  • Market Expectations: The consensus anticipates a 25-basis-point rate cut, lowering the rate from currently 6.00% to 5.75%. Historically, one in four RBI rate decisions is a surprise to the market.
  • This Insight investigates past market behavior during comparable RBI policy announcements, unearthing a surprising statistic about how the Nifty 50 might react to June’s decision, regardless of the outcome.

Aegis Vopak IPO: Anemic Demand

By Nicholas Tan

  • Aegis Vopak Terminals Ltd (1902844D IN) raised about US$328m in its upcoming India IPO.
  • It is the largest Indian third-party owner and operator (in terms of storage capacity) of tank storage terminals for liquified petroleum gas (LPG) and liquid products.
  • In our previous notes, we talked about the company’s historical performance, undertook a peer comparison and shared our thoughts on valuation. In this note, we talk about the trading dynamics.

Schloss Bangalore IPO Trading – Decent Anchor; Muted Overall Demand

By Akshat Shah

  • Schloss Bangalore Ltd (SCHBL IN) raised about US$400m in its India IPO. 
  • It is a luxury hospitality company which owns, operates, manages and develops luxury hotels and resorts under ‘The Leela’ brand, through direct ownership and hotel management agreements with third-party owners.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

Pair Trade Signal: LIC Housing Finance (LICHF IN) Long Vs. Canara Bank (CBK IN) Short

By Gaudenz Schneider

  • The Canara Bank (CBK IN) vs. LIC Housing Finance (LICHF IN) Price-Ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • The relative value opportunity can be implemented through stocks, derivatives, or as relative over-/underweights in a long only context.
  • This Insight provides a target return and discusses trade setup and risk management strategies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Leopalace21 Corp, Shanghai Rural Commercial Bank, NIFTY Index, NET Lease Office Properties, Woori Financial Group , Schloss Bangalore Ltd, Canara Bank, Renatus Tactical Acquisition Corp I and more

By | Daily Briefs, Financials

In today’s briefing:

  • [Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out
  • CSI300/CSI500/CSI1000 Index Rebalance: Changes Lead to US$12bn Trade
  • Nifty 50 and the RBI Rate Decision: History Has a Pattern
  • [Alert] Buy Net Lease Office Properties (NLOP)
  • Korean Banks; Presidential Election Drives Positive View on Hana (086790 KS) And Woori (316140 KS)
  • Schloss Bangalore IPO Trading – Decent Anchor; Muted Overall Demand
  • Pair Trade Signal: LIC Housing Finance (LICHF IN) Long Vs. Canara Bank (CBK IN) Short
  • Renatus Tactical Acquisition Corp I: SPAC with Crypto Focus and Trump-Linked Management


[Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out

By Travis Lundy

  • Leopalace21 Corp (8848 JP) had a giant oopsie in 2018-2021 where they lost ¥180bn over three years because of defective construction requiring repairs. 
  • Murakami and others got involved. Leopalace got financing from FIG (shares/SARs/loan), Murakami bailed. Eventually Hikari Tsushin got in. Leopalace got FIG out of their loan, doing a refi through Mizuho.
  • Cash was up, cashflow is strong. Business is changed/revived. Now Leopalace is buying back SARs it sold to FIG. FIG will still own 26%. The future is potentially interesting. Still. 

CSI300/CSI500/CSI1000 Index Rebalance: Changes Lead to US$12bn Trade

By Brian Freitas

  • There are 7 changes for the CSI 300 Index, 50 changes for the CSI 500 Index and 100 changes for the CSI1000 Index that will be implemented on 13 June.
  • There are 240 unique names that are adds or deletes and the round-trip trade across all 3 indices is close to US$12bn.
  • The adds have outperformed the deletes for the CSI 300 Index and the CSI 1000 Index but underperformed for the CSI 500 Index.

Nifty 50 and the RBI Rate Decision: History Has a Pattern

By Gaudenz Schneider

  • The Reserve Bank of India (RBI) is set to announce a monetary policy decision on Friday, 6 June 2025.
  • Market Expectations: The consensus anticipates a 25-basis-point rate cut, lowering the rate from currently 6.00% to 5.75%. Historically, one in four RBI rate decisions is a surprise to the market.
  • This Insight investigates past market behavior during comparable RBI policy announcements, unearthing a surprising statistic about how the Nifty 50 might react to June’s decision, regardless of the outcome.

[Alert] Buy Net Lease Office Properties (NLOP)

By Richard Howe

  • I thought I had missed NLOP. But a conversation at the Berkshire Hathaway annual meeting convinced me to take another look.
  • I told a friend that I “was pissed that I missed NLOP.” He said, “You haven’t missed it. All recourse debt has been paid off and the company is about to start paying dividends.”
  • So I made a decision to revisit NLOP with a fresh perspective.

Korean Banks; Presidential Election Drives Positive View on Hana (086790 KS) And Woori (316140 KS)

By Victor Galliano

  • The “Value Up” initiative which kicked off in February 2024 has been intended to bring about corporate governance and market reforms which minority and especially foreign investors have long sought
  • So far, these voluntary reforms have brought positive albeit limited benefits to South Korean equities; presidential elections, with potential legislative change, should act as a positive valuation driver
  • We reiterate our positive views on Woori and Hana Financial which are the top banks based on our scorecard; these attributes are due to  attractive valuations and balance sheet credentials

Schloss Bangalore IPO Trading – Decent Anchor; Muted Overall Demand

By Akshat Shah

  • Schloss Bangalore Ltd (SCHBL IN) raised about US$400m in its India IPO. 
  • It is a luxury hospitality company which owns, operates, manages and develops luxury hotels and resorts under ‘The Leela’ brand, through direct ownership and hotel management agreements with third-party owners.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

Pair Trade Signal: LIC Housing Finance (LICHF IN) Long Vs. Canara Bank (CBK IN) Short

By Gaudenz Schneider

  • The Canara Bank (CBK IN) vs. LIC Housing Finance (LICHF IN) Price-Ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • The relative value opportunity can be implemented through stocks, derivatives, or as relative over-/underweights in a long only context.
  • This Insight provides a target return and discusses trade setup and risk management strategies.

Renatus Tactical Acquisition Corp I: SPAC with Crypto Focus and Trump-Linked Management

By Special Situation Investments

  • Renatus Tactical Acquisition Corp I (RTAC) is a SPAC targeting crypto/blockchain with a $240m IPO, led by Trump Media executives.
  • RTAC units include one share and half a warrant, with a trust value of $10.025/share, trading above trust value.
  • RTAC’s sponsor sold 1.5m shares and 0.7m warrants post-IPO at $2.45/unit, below IPO price.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Zhongyuan Environment A, Aegis Vopak Terminals Ltd, Deere & Co, Elbit Systems and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Quiddity CSI 1000 Jun25 Results: 200 Changes; US$2Bn+ One-Way
  • Aegis Vopak IPO: Anemic Demand
  • Deere & Company Doubles Down on Autonomy—Will See & Spray Transform Modern Agriculture?
  • Elbit Systems: Iron Beam Laser System Advancements


Quiddity CSI 1000 Jun25 Results: 200 Changes; US$2Bn+ One-Way

By Janaghan Jeyakumar, CFA

  • The June 2025 index review results for China’s CSI 1000 index were announced after market close on Friday 30th May 2025.
  • There will be 100 ADDs/DELs for CSI 1000 in the June 2025 rebalance.
  • The CSI 1000 index rebal event could trigger US$2.2bn in one-way flow.

Aegis Vopak IPO: Anemic Demand

By Nicholas Tan

  • Aegis Vopak Terminals Ltd (1902844D IN) raised about US$328m in its upcoming India IPO.
  • It is the largest Indian third-party owner and operator (in terms of storage capacity) of tank storage terminals for liquified petroleum gas (LPG) and liquid products.
  • In our previous notes, we talked about the company’s historical performance, undertook a peer comparison and shared our thoughts on valuation. In this note, we talk about the trading dynamics.

Deere & Company Doubles Down on Autonomy—Will See & Spray Transform Modern Agriculture?

By Baptista Research

  • Deere & Company’s latest earnings report highlights both accomplishments and challenges in a complex market environment marked by global uncertainties and macroeconomic pressures.
  • The company’s second quarter performance exceeded expectations, with a commendable 18.8% margin for equipment operations amidst significant headwinds, including heightened tariff impacts and global trade volatility.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Elbit Systems: Iron Beam Laser System Advancements

By Baptista Research

  • Elbit Systems’ financial results for the first quarter of 2025 displayed strong growth and stable operational performance, continuing a trend from the past few quarters.
  • The company reported revenues of $1.896 billion, marking a significant increase from $1.554 billion for the same quarter in 2024.
  • This growth reflects a substantial demand across key markets, with Europe, North America, Asia Pacific, and Israel contributing 24%, 21%, 18%, and 32% of revenues, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Tjx Companies, NET Lease Office Properties, NVIDIA Corp, Target Corp, Home Depot Inc, Workday Inc Class A, Toll Brothers, Autodesk Inc, Lowe’s Companies Inc, Intuit Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • The TJX Companies: Leveraging Vendor Relationships For A Competitive Edge!
  • [Alert] Buy Net Lease Office Properties (NLOP)
  • Nvidia’s $3.4 Trillion AI Empire Is Just Getting Started—You Won’t Believe What’s Next!
  • Target Corporation: Will Its Investments in Digital Fulfillment and Supply Chain Pay Off?
  • How The Home Depot Plans to Capture a $50 Billion Opportunity Amid Economic Uncertainty!
  • Workday Inc.: Will Its WorkdayGO Initiatives Help to Quickly Modernize & Streamline The Enterprise Functions?
  • Toll Brothers: Will Its Spec Home Strategy & Market Adaptation Be A Breakthrough Move?
  • Autodesk Inc.: Transition to New Transaction Model to Maintain A Strong Foothold Amidst Macroeconomic Challenges!
  • Lowe’s Companies: Localization Strategy & Space Productivity Improvement to Drive Sales Growth & Market Share In The Targeted Segments!
  • Intuit Inc.: Its Expansion into QuickBooks Advanced and Intuit Enterprise Suite & Other Major Drivers!


The TJX Companies: Leveraging Vendor Relationships For A Competitive Edge!

By Baptista Research

  • The TJX Companies, Inc. reported its first-quarter results for fiscal year 2026, demonstrating resilient performance across its various divisions amidst a challenging macroeconomic environment.
  • The company achieved a 3% increase in comparable store sales, driven by higher customer transactions, with each division—both in the U.S. and internationally—contributing positively.
  • Notable growth was observed in the HomeGoods division, which outperformed its competitors, delivering a 4% increase in comp sales and a 70 basis point improvement in segment profit margin compared to the previous year.

[Alert] Buy Net Lease Office Properties (NLOP)

By Richard Howe

  • I thought I had missed NLOP. But a conversation at the Berkshire Hathaway annual meeting convinced me to take another look.
  • I told a friend that I “was pissed that I missed NLOP.” He said, “You haven’t missed it. All recourse debt has been paid off and the company is about to start paying dividends.”
  • So I made a decision to revisit NLOP with a fresh perspective.

Nvidia’s $3.4 Trillion AI Empire Is Just Getting Started—You Won’t Believe What’s Next!

By Baptista Research

  • Nvidia’s first-quarter results for fiscal 2026 showcased an extraordinary ability to maintain momentum in the face of geopolitical disruption, marking a defining moment in its trajectory as a dominant AI chipmaker.
  • The company reported a 69% year-over-year revenue surge to $44.1 billion, outperforming expectations despite the mid-April U.S. government ban on H20 GPU sales to China.
  • The data center segment remained the primary growth engine, rising 73% to $39.1 billion, driven by rising AI infrastructure demand and the adoption of its cutting-edge Blackwell architecture.

Target Corporation: Will Its Investments in Digital Fulfillment and Supply Chain Pay Off?

By Baptista Research

  • Target Corporation faced a set of challenging conditions in the first quarter of 2025, significantly impacting its overall performance.
  • The detailed analysis of the quarterly results reveals a balanced mix of positive aspects, setbacks, and strategic adjustments, offering investors insights into the company’s current standing and future priorities.
  • First-quarter sales for Target declined by 2.8%, primarily driven by a decrease in comparable sales of 3.8%.

How The Home Depot Plans to Capture a $50 Billion Opportunity Amid Economic Uncertainty!

By Baptista Research

  • The Home Depot, during its first quarter of fiscal 2025, reported sales of $39.9 billion, which represented a 9.4% increase compared to the same period last year.
  • However, the company’s comparable store sales declined slightly by 0.3%.
  • The U.S. comps showed a modest increase of 0.2%.

Workday Inc.: Will Its WorkdayGO Initiatives Help to Quickly Modernize & Streamline The Enterprise Functions?

By Baptista Research

  • Workday Inc. reported a robust first quarter of fiscal year 2026, demonstrating solid growth in key financial metrics and notable advancements in its strategic initiatives.
  • The company reported a 13% increase in subscription revenue, reaching $2.059 billion, and achieved a non-GAAP operating margin of 30.2%.
  • This performance was driven by strong customer adoption across various industries, solid contributions from their partner ecosystem, and a continued focus on AI innovation.

Toll Brothers: Will Its Spec Home Strategy & Market Adaptation Be A Breakthrough Move?

By Baptista Research

  • During its second quarter earnings for fiscal 2025, Toll Brothers, Inc. outlined its financial and operational performance amidst a challenging economic environment, providing insights into its strategies and market outlook.
  • Toll Brothers reported robust financial performance for the second quarter, achieving record second quarter home sales revenue of $2.71 billion, which surpassed the midpoint of their guidance by $236 million.
  • They delivered 2,899 homes at an average selling price of approximately $934,000.

Autodesk Inc.: Transition to New Transaction Model to Maintain A Strong Foothold Amidst Macroeconomic Challenges!

By Baptista Research

  • Autodesk delivered solid results in the first quarter of fiscal 2026, surpassing the upper limits of its guidance range for both revenue and non-GAAP earnings per share.
  • The company reported a revenue growth of 15% as reported and 16% in constant currency, with a significant contribution of $78 million from the new transaction model.
  • Billings also saw a substantial increase of 29% as reported and 30% in constant currency, reflecting a strategic shift towards annual billings for most multi-year contracts.

Lowe’s Companies: Localization Strategy & Space Productivity Improvement to Drive Sales Growth & Market Share In The Targeted Segments!

By Baptista Research

  • Lowe’s Companies, Inc. delivered a mixed performance during the first quarter of fiscal 2025, reporting total sales of $20.9 billion and a 1.7% decline in comparable sales, aligning with their expectations.
  • The results reflect challenges in the DIY segment, particularly in discretionary spending on larger ticket items, compounded by a slow start to the spring season largely due to adverse weather conditions.
  • On the positive side, the company showed strength in Pro sales, reporting mid-single-digit growth, and saw a 6% rise in online sales due to improvements in both traffic and conversion rates.

Intuit Inc.: Its Expansion into QuickBooks Advanced and Intuit Enterprise Suite & Other Major Drivers!

By Baptista Research

  • The third-quarter results for Intuit’s fiscal year 2025 illustrate a strong performance across multiple segments, driven primarily by its robust AI capabilities and strategic innovations.
  • Intuit reported a 15% increase in revenue, with significant contributions from both its Consumer Group and Global Business Solutions Group.
  • This quarter, the company raised its financial targets, attributing its success to its AI-driven platform which enhances customer interaction and streamlines processes for consumers, businesses, and accountants.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Montage Technology , HealthyWay, Shanghai Rural Commercial Bank, Bestechnic Shanghai , Zhongyuan Environment A, Contemporary Amperex Technology (CATL), Zijin Mining Group , Sichuan Biokin Pharmaceutical, Water Oasis, Softcare and more

By | China, Daily Briefs

In today’s briefing:

  • SSE50/SSE180 Index Rebalance: Some Surprises Among the Adds; Deletes as Expected
  • KWEB Index Rebalance: HealthyWay In; East Buy Out
  • CSI300/CSI500/CSI1000 Index Rebalance: Changes Lead to US$12bn Trade
  • STAR50/STAR100 Index Rebalance: 10 Changes and US$1.4bn Trade
  • Quiddity CSI 1000 Jun25 Results: 200 Changes; US$2Bn+ One-Way
  • ECM Weekly (2 June 2025) -Indigo, ITC, EBOS, Isuzu, Foshan Haitian, Lens Tech, Seres, Schloss, Aegis
  • Zijin Mining (601899 CH / 2899 HK): Evaluating the Impact of Kakula Suspension
  • China Healthcare Weekly (Jun.1)-Akeso/Summit’s Disappointing Ph3 Readout,Valuation Outlook of Biokin
  • Water Oasis H1 FY25 Results: An Improvement In Profitability And Cash 90% of Market Capitalization
  • Pre-IPO Softcare – Strong Performance Growth Momentum Would Continue


SSE50/SSE180 Index Rebalance: Some Surprises Among the Adds; Deletes as Expected

By Brian Freitas

  • There are 4 changes for the SSE50 Index (SSE50 INDEX) and 18 changes for the SSE180 Index that will be implemented at the close on 13 June.
  • The SSE50 Index (SSE50 INDEX) deletes were in line with forecasts, and the index committee has used some discretion while picking the index inclusions.
  • The SSE50 Index adds have outperformed the deletes over the last few months and there could be a further move higher in the ‘surprise’ adds to the index.

KWEB Index Rebalance: HealthyWay In; East Buy Out

By Brian Freitas


CSI300/CSI500/CSI1000 Index Rebalance: Changes Lead to US$12bn Trade

By Brian Freitas

  • There are 7 changes for the CSI 300 Index, 50 changes for the CSI 500 Index and 100 changes for the CSI1000 Index that will be implemented on 13 June.
  • There are 240 unique names that are adds or deletes and the round-trip trade across all 3 indices is close to US$12bn.
  • The adds have outperformed the deletes for the CSI 300 Index and the CSI 1000 Index but underperformed for the CSI 500 Index.

STAR50/STAR100 Index Rebalance: 10 Changes and US$1.4bn Trade

By Brian Freitas

  • There is 1 constituent change for the STAR50 INDEX and 4 changes for the STAR100 Index at the next rebalance that will be implemented at the close on 13 June.
  • We estimate turnover of 2.35% for the SSE STAR50 (STAR50 INDEX) and 4.9% for the STAR100 Index. The estimated round-trip trade is CNY 9.8bn (US$1.35bn).
  • There are multiple stocks that are adds or deletes for other indices and the passive flows will be a lot larger than just for the STAR50/STAR100 indices.

Quiddity CSI 1000 Jun25 Results: 200 Changes; US$2Bn+ One-Way

By Janaghan Jeyakumar, CFA

  • The June 2025 index review results for China’s CSI 1000 index were announced after market close on Friday 30th May 2025.
  • There will be 100 ADDs/DELs for CSI 1000 in the June 2025 rebalance.
  • The CSI 1000 index rebal event could trigger US$2.2bn in one-way flow.

ECM Weekly (2 June 2025) -Indigo, ITC, EBOS, Isuzu, Foshan Haitian, Lens Tech, Seres, Schloss, Aegis

By Sumeet Singh


Zijin Mining (601899 CH / 2899 HK): Evaluating the Impact of Kakula Suspension

By Rahul Jain

  • A 4–6 month Kakula disruption could reduce Zijin’s 2025 copper output by 4–8%, cutting EBITDA by ~7–11%.
  • Ramp-Ups at Julong and Čukaru Peki can offset ~60–70% of the lost volume and partially protect margins.
  • Lithium is expected to grow from 8% to 20% of EBITDA by 2028, driven by 300kt LCE capacity from low-cost brine assets.

China Healthcare Weekly (Jun.1)-Akeso/Summit’s Disappointing Ph3 Readout,Valuation Outlook of Biokin

By Xinyao (Criss) Wang

  • CR Sanjiu plans to transfer 49.8967% equity of Sanjiu (Anguo) and pay more attention to the quality of external M&As. China Resources+Tasly+KPC will be the core drivers of future performance.
  • Akeso’s first global phase 3 readout for ivonescimab was disappointing, which cast shadow on the final FDA approval. We shared our views on the outlook and valuation ahead.
  • The failure of HER3-DXd cast shadow over the outlook of HER3. We think Biokin is overvalued. Its valuation should be lower than Akeso and Kelun Bio.

Water Oasis H1 FY25 Results: An Improvement In Profitability And Cash 90% of Market Capitalization

By Sameer Taneja

  • Water Oasis (1161 HK)  H1 FY25 results were encouraging and a step in the positive direction as revenue/PAT improved by -2.5%/116% YoY
  • The company declared a semi-annual dividend of 3.5 cents (6.7% annualized yield) for a 43% payout ratio. Net cash of 633 million HKD represents 90% of the market capitalization.
  • Trading at 6.0x FY25 PE with earnings stabilization, this is a great name to explore, although we would like to see an improvement in capital allocation. 

Pre-IPO Softcare – Strong Performance Growth Momentum Would Continue

By Xinyao (Criss) Wang

  • Softcare has established its core competitiveness of “low price + localization”, and has achieved success in Africa. Softcare hopes to replicate its business model in Africa to other markets.
  • Emerging Markets have seen sustained growth in market penetration of baby/feminine hygiene products. We’re optimistic about Softcare’s future performance growth due to “demographic dividend + consumption upgrade” in Emerging Markets.
  • Softcare has strong fundamentals and promising outlook. We think valuation of Softcare should be higher than Hengan International Group (1044 HK) due to higher profit margin and future growth potential.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Leopalace21 Corp, Isuzu Motors, Seven & I Holdings, NTT Data Corp, TSE Tokyo Price Index TOPIX, ZOZO Inc and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out
  • [Japan Buybacks] – Buybacks Announced 26-30 May 2025 And Company Buyback History
  • Merger Arb Mondays (02 June) – Seven & I, SBI Sumishin, Shibaura, Mayne, ENN Energy, HKBN, Zeekr
  • (Mostly) Asia M&A, May 2025 Wrap: NTT Data, ZEEKR, MAC Copper, Torii, Mitsu. Shokuhin, SBI Sumishin
  • Governance Issues Were Not Highlighted and the Win-Win by REIT Sponsors and Investors Continues
  • Zozo Purchase of Lyst Is Timely


[Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out

By Travis Lundy

  • Leopalace21 Corp (8848 JP) had a giant oopsie in 2018-2021 where they lost ¥180bn over three years because of defective construction requiring repairs. 
  • Murakami and others got involved. Leopalace got financing from FIG (shares/SARs/loan), Murakami bailed. Eventually Hikari Tsushin got in. Leopalace got FIG out of their loan, doing a refi through Mizuho.
  • Cash was up, cashflow is strong. Business is changed/revived. Now Leopalace is buying back SARs it sold to FIG. FIG will still own 26%. The future is potentially interesting. Still. 

[Japan Buybacks] – Buybacks Announced 26-30 May 2025 And Company Buyback History

By Travis Lundy

  • Buybacks in Japan are becoming a much greater driver of shareholder return than in previous years. The total amount of buybacks announced just during the March-end earnings season cleared ¥7trln.
  • Quiddity has developed a buyback tool which tracks Japanese buybacks and the buyback history for any given company. Isuzu Motors (7202 JP) announced a big post-Offering buyback this week.
  • Want to see how Isuzu has executed buybacks the past decade? Daily data? % volume? You can check here for any of the 21 companies which announced buybacks this week. 


(Mostly) Asia M&A, May 2025 Wrap: NTT Data, ZEEKR, MAC Copper, Torii, Mitsu. Shokuhin, SBI Sumishin

By David Blennerhassett

  • For May 2025, 13 new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$27bn. 
  • The average premium for the new transactions announced (or first discussed) in May was ~28%, with a year-to-date average of 49%.
  • The average premiums for transactions in 2024 (129 transactions), (2023 (117), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) were 43%, 39%, 41%, 33%, 31%, and 31%.

Governance Issues Were Not Highlighted and the Win-Win by REIT Sponsors and Investors Continues

By Aki Matsumoto

  • While offering non-serious TOB prices, knowing that the likelihood of TOBs by the activist fund is low, the aim to extract concessions from the REIT and sponsor companies was successful.
  • The governance problem is the composition of the company, which continues to manage off-balance sheet real estate through its subsidiary REIT asset management company.
  • So far, however, governance issues have not received much attention, only confirming the sponsor companies’ willingness to continue REIT control and investors’ benefit from higher REIT stock prices by TOBs.

Zozo Purchase of Lyst Is Timely

By Michael Causton

  • Zozo’s purchase of UK mall Lyst will create significant synergies, allowing Zozo to build a strong base in Europe and the US.
  • The move will allow brands from Japan to sell overseas easily, while also potentially making it simple for European and US brands to sell into Japan.
  • The deal comes just in time given slowing e-commerce sales in Japan.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Suzhou Maxwell Technologies , Leopalace21 Corp, Montage Technology , Winner Medical, Isuzu Motors, Northeast Securities, HealthyWay, Washington H. Soul Pattinson and Co. Ltd, Seven & I Holdings, Shenzhen Overseas Chinese (A) and more

By | Daily Briefs, Most Read

In today’s briefing:

  • STAR&CHINEXT 50 Index Rebalance: One Change in June Adds to Other (Larger) Index Flows
  • [Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out
  • SSE50/SSE180 Index Rebalance: Some Surprises Among the Adds; Deletes as Expected
  • CSI Medical Service Index Rebalance: Six Changes with Decent Impact
  • [Japan Buybacks] – Buybacks Announced 26-30 May 2025 And Company Buyback History
  • CSI All Share IB & Brokerage Index Rebalance: Northeast Replaces Harbin Hatou
  • KWEB Index Rebalance: HealthyWay In; East Buy Out
  • Soul Patts & Brickworks: Index Impact of A$14bn Merger
  • Merger Arb Mondays (02 June) – Seven & I, SBI Sumishin, Shibaura, Mayne, ENN Energy, HKBN, Zeekr
  • CSI All Share Real Estate Sector Index Rebalance: Sector Reclassification Drives Changes


STAR&CHINEXT 50 Index Rebalance: One Change in June Adds to Other (Larger) Index Flows

By Brian Freitas


[Japan Buyback] Leopalace (8848 JP) – A Giant Buyback To Get Fortress Partially Out

By Travis Lundy

  • Leopalace21 Corp (8848 JP) had a giant oopsie in 2018-2021 where they lost ¥180bn over three years because of defective construction requiring repairs. 
  • Murakami and others got involved. Leopalace got financing from FIG (shares/SARs/loan), Murakami bailed. Eventually Hikari Tsushin got in. Leopalace got FIG out of their loan, doing a refi through Mizuho.
  • Cash was up, cashflow is strong. Business is changed/revived. Now Leopalace is buying back SARs it sold to FIG. FIG will still own 26%. The future is potentially interesting. Still. 

SSE50/SSE180 Index Rebalance: Some Surprises Among the Adds; Deletes as Expected

By Brian Freitas

  • There are 4 changes for the SSE50 Index (SSE50 INDEX) and 18 changes for the SSE180 Index that will be implemented at the close on 13 June.
  • The SSE50 Index (SSE50 INDEX) deletes were in line with forecasts, and the index committee has used some discretion while picking the index inclusions.
  • The SSE50 Index adds have outperformed the deletes over the last few months and there could be a further move higher in the ‘surprise’ adds to the index.

CSI Medical Service Index Rebalance: Six Changes with Decent Impact

By Brian Freitas

  • CSI announced the changes for the June rebalance after market close on 30 May and the changes will be effective after the close of trading on 13 June.
  • There are 6 changes for the index and we estimate passive buying of 0.7-2.4x ADV in the adds and passive selling of between 1-4.7x ADV in the deletes.
  • There will be capping inflows for Shenzhen Mindray Bio-Medical Electronics (300760 CH) and capping outflows for WuXi AppTec (603259 CH)

[Japan Buybacks] – Buybacks Announced 26-30 May 2025 And Company Buyback History

By Travis Lundy

  • Buybacks in Japan are becoming a much greater driver of shareholder return than in previous years. The total amount of buybacks announced just during the March-end earnings season cleared ¥7trln.
  • Quiddity has developed a buyback tool which tracks Japanese buybacks and the buyback history for any given company. Isuzu Motors (7202 JP) announced a big post-Offering buyback this week.
  • Want to see how Isuzu has executed buybacks the past decade? Daily data? % volume? You can check here for any of the 21 companies which announced buybacks this week. 

CSI All Share IB & Brokerage Index Rebalance: Northeast Replaces Harbin Hatou

By Brian Freitas

  • The changes to the CSI All Share Investment Banking & Brokerage Index were announced after market close on 30 May and will be implemented at the close on 13 June.
  • Northeast Securities (000686 CH) will be added to the index while Harbin Hatou Investment Co, Ltd. (600864 CH) will be deleted.
  • There is over 2.5x ADV to trade in both stocks and much smaller impact of funding/capping flows on the other index constituents.

KWEB Index Rebalance: HealthyWay In; East Buy Out

By Brian Freitas


Soul Patts & Brickworks: Index Impact of A$14bn Merger

By Brian Freitas



CSI All Share Real Estate Sector Index Rebalance: Sector Reclassification Drives Changes

By Brian Freitas

  • There are 3 adds and 4 deletes for the CSI All Share Real Estate Sector Index in June. There are changes driven by changes to the sector classification for stocks.
  • Passive trackers will need to buy between 0.2-0.65x ADV in the adds and sell between 0.15-1.75x ADV in the deletes.
  • The deletes have outperformed the adds over the last few months and some of that could dissipate over the next couple of weeks.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: A-H Premium Weekly (May 30th): Tigermed and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • A-H Premium Weekly (May 30th): Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&M Engineering


A-H Premium Weekly (May 30th): Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&M Engineering

By Ke Yan, CFA, FRM

  • We analyse the changes of A-H premium on 154 stocks over the last week. The average A-H premium was 79.2% as of May 30th.
  • The average A-H premium changed by -1.3ppt week-on-week, led by health care, information technology, utilities and offset by consumer staples, materials.
  • We highlight weekly changes in A-H premium for Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&M Engineering, Joinn Lab, Livzon Pharmaceutical.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): APAC Healthcare Weekly (June 1)- Eisai and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • APAC Healthcare Weekly (June 1)- Eisai, Daiichi, Samsung Bio, SK Bioscience, CSPC, Hengrui Pharma
  • Tariff Surge 2025: Winners, Losers, and the Real Impact on U.S. Steel and Aluminium


APAC Healthcare Weekly (June 1)- Eisai, Daiichi, Samsung Bio, SK Bioscience, CSPC, Hengrui Pharma

By Tina Banerjee

  • Eisai received approval for its insomnia drug, Dayvigo in China. Daiichi Sankyo and Merck have voluntarily withdrawn BLA seeking accelerated approval in the U.S. for patritumab deruxtecan for NSCLC.
  • Samsung Biologics secured two CMO contract worth KRW441B from unnamed pharmaceutical companies in Asia and Europe. SK Bioscience has completed a major expansion of its vaccine production facility in Andong.
  • CSPC Pharmaceutical is in negotiations regarding three potential outlicensing deals. Jiangsu Hengrui Pharmaceuticals received approvals for three drugs in China. Hansoh’s third BLA for Xinyue has been accepted by NMPA.

Tariff Surge 2025: Winners, Losers, and the Real Impact on U.S. Steel and Aluminium

By Rahul Jain

  • The U.S. has doubled tariffs on imported steel and aluminum to 50%, citing national security and domestic industry protection.
  • The move is expected to raise domestic prices, reduce imports, and increase costs for metal-intensive industries.
  • Winners include U.S.-based producers like Nucor, United States Steel, Cleveland Cliffs and Century Aluminum; losers are foreign exporters like Aloca, RioTinto, Nippon Steel, Ford, GM etc.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars